Cargando…

Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer

Currently, the same first-line chemotherapy is administered to almost all patients suffering from primary ovarian cancer. The high recurrence rate emphasizes the need for precise drug treatment in primary ovarian cancer. Being crucial in ovarian cancer progression and chemotherapeutic resistance, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dötzer, Katharina, Schlüter, Friederike, von Koch, Franz Edler, Brambs, Christine E., Anthuber, Sabine, Frangini, Sergio, Czogalla, Bastian, Burges, Alexander, Werner, Jens, Mahner, Sven, Mayer, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999332/ https://www.ncbi.nlm.nih.gov/pubmed/33809043 http://dx.doi.org/10.3390/biomedicines9030289

Ejemplares similares

Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer
por: Czogalla, Bastian, et al.
Publicado: (2022)

Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer
por: Dötzer, Katharina, et al.
Publicado: (2019)

Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
por: Hoffmann, Oliver Ingo, et al.
Publicado: (2022)

Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
por: Trillsch, Fabian, et al.
Publicado: (2023)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
por: Hiepp, Lisa, et al.
Publicado: (2022)

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
por: Czogalla, Bastian, et al.
Publicado: (2018)

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
por: Deuster, Eileen, et al.
Publicado: (2019)

High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy
por: Wrana, Friederike, et al.
Publicado: (2022)

Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
por: Czogalla, Bastian, et al.
Publicado: (2019)

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
por: Badmann, Susann, et al.
Publicado: (2020)

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation
por: Czogalla, Bastian, et al.
Publicado: (2020)

The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
por: Chen, Fangfang, et al.
Publicado: (2021)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
por: Deuster, Eileen, et al.
Publicado: (2021)

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023)

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
por: Topalov, Nicole Elisabeth, et al.
Publicado: (2021)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
por: Liao, Yue, et al.
Publicado: (2021)

Galectin-8 and -9 as prognostic factors for cervical cancer
por: Beyer, Susanne, et al.
Publicado: (2022)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

Vitamin D and VDR in Gynecological Cancers—A Systematic Review
por: Deuster, Eileen, et al.
Publicado: (2017)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
por: Kraus, Fabian B. T., et al.
Publicado: (2022)

PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer
por: Liao, Yue, et al.
Publicado: (2023)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types
por: Miksch, Rainer Christoph, et al.
Publicado: (2017)

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
por: Kaltofen, Till, et al.
Publicado: (2020)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group
por: Trillsch, Fabian, et al.
Publicado: (2021)

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
por: Beyer, Susanne, et al.
Publicado: (2020)

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
por: Kolben, Thomas, et al.
Publicado: (2022)

Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile
por: Zheng, Mingjun, et al.
Publicado: (2020)

Therapeutic Outcome of MR-Guided High-Intensity Focused Ultrasound (MR-HIFU) in Solitary versus Multiple Uterine Fibroids
por: Erber, Bernd, et al.
Publicado: (2022)

Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany
por: Kaltofen, Till, et al.
Publicado: (2021)

Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
por: Kolben, Thomas, et al.
Publicado: (2022)

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
por: Hester, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oit7ruhmp1vujmio9m14ko0af1